The Cardiovascular Effects of Alcohol Consumption: Dose-Response Relationships and Beverage Type Differences

Cardiovascular diseaseCardiovascular disease is the umbrella term for problems with the heart and blood vessels, including heart attacks, strokes, and blocked leg arteries. (CVD) remains the leading cause of morbidity and mortality globally, necessitating a rigorous evaluation of modifiable risk factorsA risk factor is something that raises your chance of developing a disease — high cholesterol particles, high blood pressure, smoking, diabetes, family history., among which alcoholAlcohol is the ingredient in beer, wine, and spirits that makes them intoxicating. consumption occupies a uniquely controversial position.[1] For decades, the medical community has observed a persistent J-shaped or U-shaped association in epidemiological data, wherein light-to-moderate consumers appear to have a lower risk of coronary heart diseaseCoronary heart disease is the narrowing or blockage of the arteries that supply blood to the heart muscle, caused by the buildup of atherosclerotic plaque; it is the leading cause of heart attack and cardiac death worldwide. (CHD) and ischemic strokeAn ischemic stroke happens when blood flow to part of the brain is blocked and brain tissue starts to die. compared to both abstainers and heavy drinkers.[1] This observation, frequently termed the “cardioprotective effect,” has been attributed to a variety of physiological mechanisms, including favorable shifts in lipid profilesA blood test panel that measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, used to assess cardiovascular risk and monitor the effect of dietary or drug interventions., improved insulin sensitivityInsulin sensitivity is how well your cells respond to insulin. It is the opposite of insulin resistance., and anti-clotting effects.[2] However, recent advancements in genetic epidemiologyEpidemiology is the study of health patterns in large groups of people — who gets sick, where, and what they had in common.—most notably Mendelian randomizationMendelian randomization is a clever research method that uses the genes people were born with as a natural experiment.—and more robust adjustments for confoundingConfounding is when a hidden third factor makes two unrelated things look connected. variables have begun to challenge the validity of this perceived benefit.[3,4] This report provides an exhaustive analysis of the dose-response relationshipA dose-response relationship describes how the magnitude of a biological effect changes as the amount of an exposure (such as weekly exercise minutes) increases; in this article, resistance training shows a non-linear dose-response for mortality, with benefits plateauing around 120 minutes per week and a J-shaped curve emerging at very high volumes in older women. between alcohol and cardiovascular health, differentiating between beverage types, exploring underlying biological mechanisms, and evaluating the net clinical impact on mortality and population-specific risks.[1]

Metabolic Pathways and the Biochemistry of Ethanol

The cardiovascular impact of alcohol begins with its metabolic transformation in the liver and subsequent interaction with systemic tissues.[2] Ethanol is primarily oxidized via a two-step enzymatic process.[2] First, alcohol dehydrogenase (ADH) converts ethanol into acetaldehydeA highly reactive and toxic intermediate produced when alcohol dehydrogenase breaks down ethanol in the liver; acetaldehyde promotes oxidative stress, damages cellular junctions, and exerts direct cardiotoxic effects, particularly in individuals with impaired aldehyde dehydrogenase activity., a highly reactive and toxic metabolite.[2] Second, aldehyde dehydrogenase (ALDH) converts acetaldehyde into acetate, a relatively benign substance that is eventually broken down into carbon dioxide and water.[2]

The efficiency of this pathway is a critical determinant of individual susceptibility to alcohol-related harm.[5] In populations with high frequencies of the ALDH2The gene encoding aldehyde dehydrogenase 2, which converts acetaldehyde—a toxic ethanol metabolite—into harmless acetate; individuals carrying the ALDH2*2 variant, common in East Asian populations, have impaired enzyme activity, leading to acetaldehyde accumulation, flushing syndrome, and heightened cardiotoxic risk when drinking.*2 allele, particularly in East Asia, the second step of metabolism is impaired, leading to the accumulation of acetaldehyde.[5] This accumulation results in the “flushing syndrome” characterized by facial erythema, tachycardia, and nausea, and serves as a natural deterrent to heavy consumption.[5] However, for those who continue to drink despite this genetic predisposition, the elevated levels of acetaldehyde exert direct cardiotoxic effects, promoting oxidative stressOxidative stress is an imbalance between damaging reactive molecules and the body's ability to neutralize them. and damaging cellular junctions.[5-7]

The metabolic process also significantly alters the cellular redox state.[2] The conversion of ethanol and acetaldehyde requires the reduction of nicotinamide adenine dinucleotide (NAD+) to NADH.[2] The resulting increase in the NADH/NAD+ ratioA measure of the cellular redox state reflecting the balance between the reduced (NADH) and oxidized (NAD+) forms of nicotinamide adenine dinucleotide; ethanol metabolism raises this ratio in liver cells, suppressing gluconeogenesis and shifting hepatic metabolism toward fatty acid synthesis, which contributes to hypertriglyceridemia and may accelerate atherosclerosis in heavy drinkers. suppresses gluconeogenesis and shifts hepatic metabolism toward fatty acid synthesis, contributing to hypertriglyceridemia and potentially accelerating the early stages of atherosclerosisAtherosclerosis is the disease behind most heart attacks and many strokes. Cholesterol particles get stuck in the wall of an artery, the body sends immune cells to clean up, and over years that mess hardens into plaque. in heavy drinkers.[2]

Dose-Response Relationships: The J-Shaped Curve Re-evaluated

Central to the discussion of alcohol and cardiovascular health is the definition of consumption levels and the standard drink.[8] In the United States, a standard drink contains approximately 14 grams of pure ethanol, though international definitions vary.[8]

Observational Evidence for Cardioprotection

Traditional prospective cohortA prospective cohort enrolls healthy people, records their characteristics, and then waits to see what happens. studies have consistently identified a J-shaped curveA statistical pattern in epidemiological data where light-to-moderate consumers of alcohol appear to have lower cardiovascular risk than both abstainers and heavy drinkers, producing a curve shaped like the letter J when risk is plotted against consumption level; the validity of this pattern has been increasingly challenged by Mendelian randomization studies and better adjustment for confounding. for various cardiovascular outcomes.[1] A recent meta-analysisA meta-analysis statistically combines the results of many separate studies into one overall estimate. of observational data indicated that moderate drinkers experience a 12% lower risk of myocardial infarctionSee Heart Attack for the full entry. (RR = 0.88) and an 11% lower risk of total strokeA stroke happens when blood flow to part of the brain stops, either from a blockage or from bleeding. (RR = 0.89) compared to never-consumers.[1,9] This numeric alignment is important: an RR of 0.88 corresponds to a 12% relative reduction, not a 22% reduction, and careful reporting of effect sizes prevents overstatement while preserving interpretability across outcomes.[1,9] The nadir of this curve, representing the lowest risk, is typically observed at consumption levels of approximately 1 to 2 drinks per day for coronary heart disease and <= 1 drink per day for stroke mortality.[1]

Methodological Bias and Causal Inference

The perceived protective effect of moderate drinking is increasingly scrutinized due to several endemic biases in observational research:[1]

1. Sick Quitter BiasA form of selection bias in alcohol research in which former drinkers who stopped due to illness are grouped with lifelong abstainers, making the non-drinking reference group appear unhealthier than it truly is and artificially inflating the apparent benefit of moderate drinking.: Former drinkers, who may have abstained due to alcohol-related health issues or medications, are often grouped with life-long abstainers. This makes the “moderate” drinking group appear healthier by comparison.[1]
2. Healthy User BiasA confounding phenomenon in which moderate drinkers tend to have higher socioeconomic status, better diets, and more active lifestyles, making alcohol appear protective when it may simply be a marker for other health-promoting behaviors.: Moderate alcohol consumption is often a marker for higher socioeconomic status, better dietary habits (such as the Mediterranean dietThe Mediterranean diet emphasizes vegetables, fruit, beans, whole grains, nuts, and olive oil, with fish and little red meat.), and increased physical activity—all of which independently reduce cardiovascular risk.[1]
3. Underreporting: Self-reported data often underestimate actual intake, potentially leading to the misclassification of heavy drinkers as moderate ones.[2]

Mendelian randomizationRandomization is the process of assigning trial participants to treatment or control groups by chance, ensuring that known and unknown confounding factors are evenly distributed; when randomization fails—as auditors found occurred in PREDIMED—the groups may differ in ways that distort the apparent treatment effect. (MR) studies, which use genetic variants like ADH1BThe gene encoding alcohol dehydrogenase 1B, the enzyme responsible for the first step in ethanol metabolism; genetic variants in ADH1B (notably rs1229984) influence how quickly alcohol is broken down and are commonly used as instrumental variables in Mendelian randomization studies of alcohol and cardiovascular risk. (rs1229984) and ALDH2 (rs671) as instrumental variables, have provided a different perspective.[3,4] Because alleles are randomly assigned at conception, they are less prone to the lifestyle confoundersA confounder is a variable that is associated with both the exposure being studied (such as TMAO) and the outcome (such as heart disease), making it appear as though one causes the other when a third factor is actually responsible. The article lists renal function, insulin resistance, systemic inflammation, and age as major confounders that inflate the apparent cardiovascular risk of high TMAO in… that plague observational studies.[3,4] Large-scale MR analyses, including data from the Million Veteran ProgramThe Million Veteran Program is a large US biobank and genomic research initiative drawing on veterans' health data; genetic analyses from this cohort have been used to identify causal relationships between ApoB-raising gene variants and conditions such as peripheral artery disease. and UK BiobankUK Biobank holds detailed genetic, lifestyle, and health data on half a million British volunteers, linked to their medical records., have largely failed to support the protective effect.[3,4] Instead, they often demonstrate a linear increase in risks for hypertensionHypertension is the medical term for high blood pressure. and coronary artery diseaseCoronary artery disease is plaque buildup in the arteries feeding the heart muscle. across all levels of alcohol consumption, suggesting that any benefit observed in traditional studies is likely non-causal.[3,4]

Alcohol and the Pathogenesis of Atherosclerosis

Atherosclerosis, the thickening and hardening of arterial walls due to plaquePlaque is the buildup of cholesterol, immune cells, scar tissue, and calcium inside an artery wall. accumulation, is the underlying cause of most cardiovascular events.[2] Alcohol’s effect on this process is multi-factorial, involving lipids, inflammatory markers, and endothelial functionThe ability of the inner lining of blood vessels to regulate vascular tone, inflammation, and clotting; healthy endothelial cells release nitric oxide to keep arteries relaxed and resistant to plaque formation..[2]

Lipids and Lipoproteins

One of the most robust observational findings is the positive association between alcohol intake and high-density lipoproteinA lipoprotein is a tiny package that carries fat and cholesterol through your bloodstream. Since fat won't dissolve in water, it needs a protein wrapper to travel. (HDLHDL, or high-density lipoprotein, is the particle often called "good cholesterol." It picks up cholesterol from tissues and carries it back to the liver.) cholesterolCholesterol is a waxy substance your body needs. It goes into cell walls, hormones, vitamin D, and the bile that digests your food. You would die without it..[2] Ethanol increases the production of apolipoproteinsAn apolipoprotein is a protein attached to a fat-carrying particle in your blood. Fat and water don't mix, so these proteins act like a wrapper that lets fat travel safely through the bloodstream. A-I and A-II and the transport rate of HDL subfractions.[2]

While HDL has historically been considered “good” cholesterol, the alcohol-induced increase in HDL does not necessarily translate into a reduction in cardiovascular risk.[3,4] Mendelian randomization studies have shown that increasing HDL through alcohol does not have a clear causal link to reduced myocardial infarction risk, suggesting that the functional quality of the HDL particles or the pathways involved may be more important than the absolute concentration.[3,4]

Inflammation and Biomarkers

Low-grade systemic inflammationInflammation is your immune system's response to injury or something it treats as an invader. It brings swelling, heat, and cleanup cells. is a critical driver of atherosclerotic progression.[2] Moderate alcohol consumption has been associated with lower levels of C-reactive proteinC-reactive protein, or CRP, is a substance your liver makes when there is inflammation somewhere in your body. A sensitive version of the test, hs-CRP, is used to estimate heart risk. (CRP), fibrinogen, and Interleukin-6 (IL-6)A signaling protein produced in response to IL-1β during plaque inflammation that travels to the liver and stimulates CRP production; elevated circulating IL-6 therefore reflects active vascular inflammation. in observational studies.[2] However, the causal nature of these associations is questionable.[20,21] One-sample and two-sample MR analyses have suggested that while CRP is a strong predictive marker for ischemic stroke and death, it does not have a causal role in these outcomes.[20] Similarly, genetic evidence suggests that the relationship between alcohol and inflammation markers may be confounded by factors like smokingSmoking damages the lining of your blood vessels, raises blood pressure, makes blood clot more easily, and speeds up plaque growth. and body mass indexBody mass index, or BMI, is a number calculated from your height and weight, used as a rough measure of body size., and by correlated health behaviors that cluster with beverage choice and drinking pattern.[21]

Endothelial Function and Imaging

Healthy endothelial function is essential for vascular homeostasis, mediated primarily through nitric oxideNitric oxide is a gas your blood vessel lining makes to tell the vessel to relax and widen. (NO) production.[2] Moderate intake, particularly of red wine, has been shown to acutely improve flow-mediated vasodilation (FMD).[22] In contrast, chronic heavy drinking impairs endothelial function, promotes oxidative stress, and contributes to arterial stiffening.[2]

Imaging studies provide an objective look at subclinical atherosclerosisSubclinical atherosclerosis means plaque is present but has not yet caused any symptoms or events..[10,11] The relationship between alcohol and carotid intima-media thickness (cIMT)Carotid intima-media thickness is an ultrasound measurement of the combined thickness of the inner two layers of the carotid artery wall in the neck; a faster rate of thickening indicates accelerating atherosclerosis, and it is used as a surrogate marker for cardiovascular risk in trials such as ELITE. or coronary artery calcium (CAC)Coronary artery calcium is a measure of calcified plaque deposits in the walls of the coronary arteries, quantified by CT scan and expressed as an Agatston score; higher scores indicate greater cumulative plaque burden and predict future cardiovascular events. scores remains inconsistent.[10,11] While some Japanese studies have found lower cIMT in moderate drinkers compared to never-drinkers, larger consortia like the USE-IMT have reported more complex, often null, associations after adjusting for cardiovascular risk factors.[10] A longitudinal studyA research design that follows the same individuals over an extended period to observe how exposures or traits at one time point relate to outcomes—such as mortality—years or decades later. in Sweden found no association between midlife alcohol intake and the presence of carotid plaque or IMT at age 60, further suggesting that the atherosclerotic benefits of alcohol may be overstated and may reflect selection and residual confoundingThe bias that remains in an observational study even after statistical adjustment, because some shared risk factors — such as poverty, smoking, or diabetes — cannot be fully measured or removed; with a modest relative risk like 1.20, residual confounding alone could plausibly explain the entire observed association. rather than durable plaque-level protection.[11]

Cardiac Arrhythmogenesis: Atrial Fibrillation and Beyond

While alcohol may have mixed effects on coronary disease, its role as a pro-arrhythmic agent is well-established.[12,28] The most common arrhythmia associated with alcohol use is atrial fibrillationAtrial fibrillation, often shortened to AFib, is a fast and irregular heartbeat that starts in the upper chambers of the heart. (AF).[12,28]

Atrial Fibrillation and the “Holiday Heart”

The association between heavy alcohol consumption and new-onset AF, often occurring after binge episodes, is known as “Holiday Heart SyndromeThe phenomenon in which binge alcohol consumption triggers acute atrial fibrillation or other arrhythmias, classically observed after holiday celebrations; it demonstrates that even isolated episodes of heavy drinking can destabilize the heart's electrical system without requiring underlying structural disease.”.[28] However, even moderate consumption is linked to a heightened risk.[12,15] Meta-analyses of over 10 million participants show that for every additional drink per day (often modeled as ~12 g ethanol/day increments), the risk of AF increases by approximately 6% to 8%.[9,12]

Electrophysiological and Structural Mechanisms

The mechanisms by which alcohol induces AF are both acute and chronic:[28,29,31]

1. Electrophysiological Changes: Alcohol acutely shortens the effective refractory period (ERP)The minimum time interval after an electrical impulse during which cardiac tissue cannot be re-stimulated; alcohol acutely shortens the atrial ERP, particularly in the pulmonary veins, making the heart more susceptible to the re-entrant electrical circuits that underlie atrial fibrillation. of the atria, particularly in the pulmonary veins, making the heart more susceptible to re-entrant circuits.[28]
2. Structural Remodeling: Chronic consumption is associated with left atrial enlargementStructural expansion of the left atrium of the heart, associated with chronic alcohol consumption; the enlarged and remodeled atrium develops low-voltage zones (fibrotic areas) that act as substrates sustaining persistent atrial fibrillation. and the development of low-voltage zones (fibrosis), which serve as substrates for persistent AF.[28]
3. Autonomic Nervous System: Alcohol stimulates the sympathetic component while reducing heart rate variabilityHeart rate variability (HRV) is the natural beat-to-beat variation in the time between heartbeats, and is used as a non-invasive measure of autonomic nervous system balance — higher variability generally reflecting greater parasympathetic (rest-and-digest) activity. It is listed in the article as one of the outcomes measured in meditation trials., creating a state of autonomic imbalance that favors arrhythmias.[28]
4. Ion Channel Modulation: Ethanol and acetaldehyde can disrupt L-type calcium channels and sodium channels, leading to intracellular calcium imbalance and electrical instability.[29]

Cerebrovascular Risk: The Stroke Subtype Dichotomy

The impact of alcohol on stroke is highly heterogeneous and depends heavily on the subtype (ischemic vs. hemorrhagic) and the pattern of drinking.[1,23]

Ischemic Stroke

Observational meta-analyses often report a J-shaped relationship for ischemic stroke.[1,23] Moderate drinkers (1–2 drinks/day) show a reduced risk (RR = 0.83 to 0.87), whereas heavy drinkers experience a significant increase in risk (RR = 1.31).[1,23] The perceived benefit at lower doses is thought to be mediated by alcohol’s anti-thrombotic properties, including reduced fibrinogen levels and decreased platelet reactivity.[2,24] However, MR studies using the ADH1B variant suggest that any reduction in alcohol intake is associated with a reduced risk of ischemic stroke, implying that the “cardioprotective” observational findings may be due to selection bias.[3,4]

Hemorrhagic Stroke

In stark contrast, the relationship between alcohol and hemorrhagic strokeA hemorrhagic stroke is a type of stroke caused by bleeding into or around the brain rather than by a blocked artery; because aspirin impairs clotting, it raises the risk of this complication, which is a key reason its use in low-risk individuals is now discouraged. appears to be more linear.[1,23] Current alcohol consumers have approximately a 14% increased risk for hemorrhagic stroke compared to nondrinkers, a risk that increases steadily with the amount consumed.[1,23] This is likely driven by alcohol’s effect on blood pressureBlood pressure is the force of blood pushing against your artery walls. It is written as two numbers, like 120/80. The top number is the pressure when your heart squeezes, the bottom is when it relaxes. and its impairment of primary hemostasis.[2] Binge drinking, in particular, causes transient but sharp increases in blood pressure that can trigger acute intracerebral hemorrhage.[2]

Myocardial Structure and Alcoholic Cardiomyopathy

Chronic heavy alcohol consumption can lead to alcoholic cardiomyopathy (ACM)A form of dilated cardiomyopathy caused by chronic heavy alcohol use—typically defined as approximately 80 grams of ethanol daily for at least five years—in which sustained ethanol toxicity weakens and enlarges the heart muscle; unlike many causes of heart failure, ACM is often substantially reversible with sustained abstinence., a form of non-ischemic dilated cardiomyopathyCardiomyopathy is disease of the heart muscle itself, rather than of the arteries feeding it. characterized by ventricular dilation and impaired systolic function.[14,15]

Thresholds and Pathophysiology

ACM typically develops after long-term exposure to high levels of ethanol.[14,15] While definitions vary, the classic threshold is often cited as the consumption of more than 80 grams of ethanol per day for at least five years.[14,15] This condition accounts for a clinically meaningful fraction of non-ischemic dilated cardiomyopathies, although the exact proportion varies widely by cohort, ascertainment method, and exposure definition, and reported estimates can span broad ranges across clinical series and population studies.[15]

The pathogenesis of ACM involves:

• Direct Toxicity: Ethanol and acetaldehyde induce oxidative stress, impairing proteinProtein is the nutrient your body uses to build and repair muscle and tissue. synthesis and causing mitochondrial dysfunction in cardiomyocytes.[15]
• Activation of the Renin-Angiotensin System: Chronic use stimulates neurohormonal pathways that promote myocardial fibrosis and remodeling.[15]
• Nutritional Deficiencies: While alcohol is a primary toxin, secondary factors like thiamine deficiency (Beriberi) can exacerbate cardiac dysfunction in some patients.[14,15]

Reversibility and Prognosis

A defining characteristic of ACM is its potential for reversibility.[14,15] Unlike idiopathic dilated cardiomyopathy, ACM often shows significant improvement in left ventricular ejection fractionThe percentage of blood pumped out of the heart's main pumping chamber with each beat; a normal value is 55 percent or above, and a rising ejection fraction after heart disease is a measurable sign of cardiac recovery. (LVEF) and clinical symptoms upon total abstinence from alcohol.[15,25] Even in patients with advanced disease, early intervention and cessation of drinking can lead to a favorable prognosis and stabilization of heart failureHeart failure means the heart cannot pump well enough to meet the body's needs. The name is misleading — it does not mean the heart has stopped..[15,25]

Beverage Type Comparison: Wine, Beer, and Spirits

A persistent question in cardiovascular research is whether the type of beverage consumed matters.[16,18] The “French ParadoxThe French Paradox is the observation that France had relatively low coronary heart disease mortality in the 1980s and 1990s despite high saturated fat consumption; analyses have attributed this apparent paradox to a time-lag in France's adoption of high-fat diets compared with other Western nations, systematic under-certification of CHD deaths by French physicians, and the cumulative nature of a…” popularized the idea that red wine, in particular, offers unique protection due to its high concentration of polyphenolsPolyphenols are a broad class of plant-derived compounds with antioxidant properties; extra virgin olive oil is particularly rich in them, and they are often cited as the reason EVOO may be more protective than refined olive oil, though trials measuring hard cardiovascular endpoints have not confirmed a meaningful clinical benefit. like resveratrol.[22]

Wine vs. Beer vs. Spirits

Meta-analyses of beverage types suggest that wine drinkers often have the lowest relative riskRelative risk compares two groups: this group had 30 percent fewer heart attacks than that group. for cardiovascular mortality, followed by beer, with spirits often showing a null or less favorable effect, although the magnitude of these differences is highly sensitive to confounding control, socioeconomic patterning, and smoking-related covariation.[18]

These estimates should be interpreted as observationally associated risks rather than causal pharmacologic effects; across datasets, effect sizes may shift toward null after fuller adjustment for diet quality, income, healthcare access, and smoking intensity, and the “wine advantage” can shrink materially when beverage choice is treated as a behavioral cluster rather than an isolated exposure.[18]

The Polyphenol Controversy

Experimental studies have demonstrated that red wine polyphenols can enhance NO bioavailability, reduce oxidative stress, and inhibit platelet aggregation more effectively than ethanol alone.[22] Some studies using dealcoholized red wine have shown that these vascular benefits can be achieved without the harmful effects of ethanol.[22]

However, the epidemiological “wine advantage” is likely heavily confounded.[18] Wine drinkers consistently buy healthier foods, have higher socioeconomic status, and are less likely to smoke compared to beer or spirit drinkers.[18] When studies are meticulously adjusted for these factors, the difference between wine and other beverage types often diminishes, suggesting that the ethanol component and the associated lifestyle may be the primary drivers of any observed benefit.[18]

Mortality Outcomes and Global Burden

The cardiovascular effects of alcohol must be situated within the broader context of global health and all-cause mortalityAll-cause mortality means death from any cause at all, not just heart disease — the broadest, hardest-to-game outcome a study can measure..[17,27]

Cardiovascular vs. All-Cause Mortality

While moderate consumption may be associated with reduced cardiovascular mortality in some observational cohorts (RR = 0.82), this benefit is often offset by increases in other causes of death, particularly cancer and accidents.[1] The 2021 Global Burden of Disease (GBD) study highlights that alcohol use remains a top risk factor for global disease burden, ranking as the 10th leading risk factor for all deaths and the number one risk factor for those aged 15–49.[27]

Recent Trends and Regional Differences

Global deaths attributable to high alcohol use doubled between 1990 and 2021, though age-standardized mortality rates have declined in some regions due to improvements in overall healthcare.[27] Eastern Europe continues to experience the highest burden of alcohol-related CVD, while regions like Southeast Asia are seeing dramatic increases in years of life lost (DALYs) due to rising consumption levels.[27]

Genetic Variability and Population Differences

Individual responses to alcohol are not uniform and are profoundly shaped by genetics and baseline health status.[5-7]

Genetic Markers of Sensitivity

The ADH1B (rs1229984) and ALDH2 (rs671) variants are the most studied genetic determinants of alcohol-related cardiovascular risk.[3-7]

• ADH1B (rs1229984): Individuals with this variant metabolize ethanol to acetaldehyde more quickly, leading to higher levels of this toxin and generally lower alcohol consumption. These individuals consistently show a lower risk of CHD and stroke in MR studies, regardless of their self-reported intake.[3,4]
• ALDH2 (rs671): This variant, prevalent in East Asians, impairs the clearance of acetaldehyde. Carriers who continue to drink heavily have a markedly increased risk of ischemic stroke and coronary arteryAn artery is a blood vessel that carries blood away from the heart to the rest of the body. disease compared to non-carriers.[5-7]

Sex-Specific Differences

Women often experience higher blood alcohol concentrations for a given dose compared to men, due to lower levels of gastric alcohol dehydrogenase and a smaller volume of distribution for ethanol.[2] While observational data suggest a J-shaped curve for AF in women, the linear risk in men appears more robustly established.[12,15] Furthermore, heavy consumption increases breast cancer risk in women even at low levels, complicating the risk-benefit analysis of “moderate” drinking.[1]

Risk-Benefit Analysis and Current Guidelines

The debate over whether any level of alcohol is “safe” has reached a critical juncture.[19,20] Current recommendations from major health organizations emphasize caution and personal risk assessment.[13,19]

Comparing Professional Guidelines (2024-2025)

The American Heart Association (AHA), American College of Cardiology (ACC), and the World Health Organization (WHO) have increasingly harmonized their messages, shifting away from endorsing moderate alcohol for health benefits.[13,19]

Net Clinical Benefit vs. Cancer Risk

A significant factor in the changing perception of alcohol is the strong evidence linking it to various cancers, including those of the mouth, throat, esophagus, liver, and breast.[1,19] The International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen.[1] For many individuals, the marginal (and potentially non-causal) cardiovascular benefit of one drink per day is outweighed by the lifelong cumulative increase in cancer risk.[1,19]

Clinical Synthesis and Evidence-Based Conclusion

The comprehensive evaluation of the cardiovascular effects of alcohol reveals a complex landscape where observational benefits are increasingly at odds with genetic and causal inference data.[1,3,4]

1. Dose-Response Summary: While observational studies continue to produce J-shaped curves for myocardial infarction and ischemic stroke, newer genetic methodologies (Mendelian randomization) suggest these benefits may be artifacts of confounding and lifestyle factors.[1,3,4] In contrast, the risks for hypertension, atrial fibrillation, and hemorrhagic stroke appear to increase linearly or exponentially with consumption.[3,4,12,15]
2. Atherosclerosis and Mechanisms: Alcohol increases HDL cholesterol and decreases fibrinogen, but these changes do not consistently result in reduced structural atherosclerosis as measured by arterial imaging.[2,10,11] Heavy intake remains a primary driver of vascular damage and systemic inflammation.[2]
3. Arrhythmic Impact: There is no clear safe threshold for alcohol regarding atrial fibrillation.[12,15] Alcohol induces both acute electrical changes and chronic structural remodeling (atrial fibrosisMicroscopic scarring of atrial muscle tissue, often resulting from chronic mechanical stretch or inflammation; fibrosis disrupts normal electrical conduction and is a well-established predictor of AF recurrence after ablation.) that increase the burden of arrhythmias.[12,28,29,31]
4. Stroke Subtypes: A critical dichotomy exists between ischemic and hemorrhagic stroke.[1,23] Any anti-thrombotic benefit for ischemic stroke is counteracted by the significant increase in hemorrhagic risk, particularly during binge drinking or in individuals with pre-existing hypertension.[1,2,23]
5. Beverage Type: The perceived superiority of red wine is likely a reflection of the “healthy user” profile of wine drinkers rather than a unique pharmacological property of wine polyphenols.[18,22] Ethanol itself remains the primary active agent influencing cardiovascular outcomes.[2]
6. Cardiomyopathy: Chronic heavy drinking (80g/day) is a preventable cause of heart failure.[14,15] ACM is uniquely characterized by its potential for reversibility upon total abstinence.[15,25]

The evidence-based conclusion is that while low-to-moderate alcohol consumption may be statistically associated with certain lower cardiovascular risks in observational cohorts, the benefit is likely overstated and may be non-causal.[1,3,4] High consumption and binge drinking clearly cause substantial harm to cardiac structure and function.[2,12,14,15] From a public health and clinical management perspective, the safest level of consumption is low or zero, especially for populations at high risk for arrhythmias, stroke, or cancer.[1,19] Patients should be counseled that if they do not currently consume alcohol, there is no evidence-based reason to start for “heart health.”[19] Those who do drink should be advised to remain strictly within the limits of one drink per day for women and two for men, with frequent alcohol-free days to mitigate the risk of cumulative structural damage.[19]

References

1. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee on Review of Evidence on Alcohol and Health, Stone KB, Calonge BN, eds. Review of Evidence on Alcohol and Health. Washington (DC): National Academies Press (US); April 23, 2025.
2. Piano MR. Alcohol’s Effects on the Cardiovascular System. Alcohol Res. 2017;38(2):219-241. doi:10.35946/arcr.v38.2.06
3. Larsson SC, Burgess S, Mason AM, Michaëlsson K. Alcohol Consumption and Cardiovascular Disease: A Mendelian Randomization Study. Circ Genom Precis Med. 2020;13(3):e002814. doi:10.1161/CIRCGEN.119.002814
4. Chien PS, Wong TJ, Tai AS, Shr YH, Yu T. Examining the causal association between moderate alcohol consumption and cardiovascular risk factors in the Taiwan Biobank: a Mendelian randomization analysis. Front Cardiovasc Med. 2024;11:1456777. Published 2024 Oct 2. doi:10.3389/fcvm.2024.1456777
5. Tadokoro T, Oura K, Nakahara M, et al. Genetic Polymorphisms of ALDH2 and ADH1B in Alcohol-Induced Liver Injury: Molecular Mechanisms of Inflammation and Disease Progression in East Asian Populations. Int J Mol Sci. 2025;26(17):8328. Published 2025 Aug 28. doi:10.3390/ijms26178328
6. Li YY, Wang H, Wu JJ, et al. ALDH2 gene G487A polymorphism and coronary artery disease: a meta-analysis including 5644 participants. J Cell Mol Med. 2018;22(3):1666-1674. doi:10.1111/jcmm.13443
7. Sung YF, Lee JT, Hu CJ, Jeng JS, Chiou HY, Peng GS. Impact of ALDH2 genotypes and alcohol consumption on age at first-ever ischemic stroke: A cohort study in Taiwan. Alcohol Clin Exp Res (Hoboken). 2026;50(1):e70217. doi:10.1111/acer.70217
8. Centers for Disease Control and Prevention. About moderate alcohol use. CDC website. Published 2025. https://www.cdc.gov/alcohol/about-alcohol-use/moderate-alcohol-use.html
9. Jiang H, Mei X, Jiang Y, et al. Alcohol consumption and atrial fibrillation risk: An updated dose-response meta-analysis of over 10 million participants. Front Cardiovasc Med. 2022;9:979982. Published 2022 Sep 30. doi:10.3389/fcvm.2022.979982
10. Britton AR, Grobbee DE, den Ruijter HM, et al. Alcohol Consumption and Common Carotid Intima-Media Thickness: The USE-IMT Study. Alcohol Alcohol. 2017;52(4):483-486. doi:10.1093/alcalc/agx028
11. Dahlin Almevall A, Wennberg P, Nyman E, et al. Low to moderate alcohol consumption across two decades and subclinical atherosclerosis at age 60: findings from the Northern Sweden Västerbotten Intervention Programme-visualisation of atherosclerosis (VIPVIZA) study. Front Cardiovasc Med. 2026;12:1710165. Published 2026 Jan 7. doi:10.3389/fcvm.2025.1710165
12. Surma S, Lip GYH. Alcohol and Atrial Fibrillation. Rev Cardiovasc Med. 2023;24(3):73. Published 2023 Mar 1. doi:10.31083/j.rcm2403073
13. Gulati, M, Moore, M, Cibotti-Sun, M. 2025 High Blood Pressure Guideline-at-a-Glance. JACC. 2025 Nov, 86 (18) 1560–1566. https://doi.org/10.1016/j.jacc.2025.07.010
14. Shaaban A, Gangwani MK, Pendela VS, et al. Alcoholic Cardiomyopathy. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513322/
15. Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: an update. Eur Heart J. 2024;45(26):2294-2305. doi:10.1093/eurheartj/ehae362
16. Harvard T.H. Chan School of Public Health. Is wine fine, or beer better? The Nutrition Source. https://nutritionsource.hsph.harvard.edu/is-wine-fine-or-beer-better/
17. Institute for Health Metrics and Evaluation. Alcohol use. IHME website. https://www.healthdata.org/research-analysis/health-topics/alcohol-use
18. Lucerón-Lucas-Torres M, Saz-Lara A, Díez-Fernández A, et al. Association between Wine Consumption with Cardiovascular Disease and Cardiovascular Mortality: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(12):2785. Published 2023 Jun 17. doi:10.3390/nu15122785
19. Piano MR, Marcus GM, Aycock DM, et al. Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2025;152(1):e7-e21. doi:10.1161/CIR.0000000000001341
20. Rolver MG, Emanuelsson F, Nordestgaard BG, Benn M. C-reactive protein and prospective cardiometabolic risk: observational and Mendelian randomization study of ischemic stroke and all-cause death. Cardiovasc Diabetol. 2025;25(1):11. Published 2025 Dec 11. doi:10.1186/s12933-025-03028-5
21. Bekkevold OJ, Damås JK, Brumpton BM, Åsvold BO. The causal role of C-reactive protein and interleukin-6 on anxiety and depression symptoms and life satisfaction: Mendelian randomisation analyses in the HUNT study. Psychol Med. 2023;53(16):7561-7568. doi:10.1017/S0033291723001290
22. Li H, Förstermann U. Red wine and cardiovascular health. Circ Res. 2012;111(8):959-961. doi:10.1161/CIRCRESAHA.112.278705
23. Toubasi AA, Al-Sayegh TN. Alcohol Use and Types and Ischemic Stroke: A Systematic Review and Meta-Analysis. Eur Neurol. 2025;88(3-4):140-150. doi:10.1159/000547945
24. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319(7224):1523-1528. doi:10.1136/bmj.319.7224.1523
25. Estruch R, Fernández-Solá J, Mont L, et al. Reversibilidad de la miocardiopatía alcohólica con la abstinencia: presentación de dos casos [Reversibility of alcoholic myocardiopathy with abstinence: presentation of 2 cases]. Med Clin (Barc). 1989;92(2):69-71.
26. Howie EK, Sui X, Lee DC, Hooker SP, Hébert JR, Blair SN. Alcohol consumption and risk of all-cause and cardiovascular disease mortality in men. J Aging Res. 2011;2011:805062. doi:10.4061/2011/805062
27. Niu C, Dong J, Zhang P, et al. The global burden of cardiovascular disease attributable to high alcohol use from 1990 to 2021: an analysis for the global burden of disease study 2021. Front Public Health. 2025;13:1541641. Published 2025 Feb 14. doi:10.3389/fpubh.2025.1541641
28. Qiao Y, Shi R, Hou B, et al. Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation. J Am Heart Assoc. 2015;4(11):e002349. Published 2015 Nov 9. doi:10.1161/JAHA.115.002349
29. Huang Z, Luo C, Wu Z, Zheng B. Electrophysiological Mechanisms and Therapeutic Potential of Calcium Channels in Atrial Fibrillation. Rev Cardiovasc Med. 2025;26(6):33507. Published 2025 Jun 25. doi:10.31083/RCM33507